Validation of a Urine-based Assay With Genomic Markers for Predicting Recurrence for Non-muscle Invasive Bladder Cancer

Characterizing the Microvascular Environment of Bladder Cancer With Super-Resolution Ultrasound Localization Microscopy

NCT06986304 ·Status: RECRUITING

Identifying Methylation Biomarkers for Monitoring Bladder Tumors

NCT00244205 ·Status: UNKNOWN

Evaluating Bladder CARE™, a New Non-Invasive Urine Test, for Bladder Cancer Detection in Inconclusive Cases

NCT06870253 ·Status: ACTIVE_NOT_RECRUITING

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

NCT01050504 ·Status: RECRUITING

Bladder Tumor Biopsy Study to Improve Preoperative Determination of Stage and Grade

NCT02992990 ·Status: UNKNOWN ·Phase: NA

Assessement of the Concordance of Genomic Alterations Between Urine and Tissue in High-Risk NMIBC Patients

NCT04412070 ·Status: TERMINATED

Bladder Cancer Patient-Reported Outcomes

NCT01090388 ·Status: COMPLETED

Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer

NCT02716961 ·Status: UNKNOWN ·Phase: NA

a Genome-based Platform to Predict Patients That Can Achieve Bladder Preservation in Muscle Invasive Bladder Cancer Patients

NCT04686149 ·Status: UNKNOWN

Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer

NCT01589094 ·Status: COMPLETED ·Phase: PHASE2

Longitudinal Bladder Cancer Study for Tumour Recurrence

NCT05080998 ·Status: RECRUITING

Guiding Value of Urinary Tumor DNA Testing in Repeat Transurethral Resection of Non-Muscle-Invasive Bladder Cancer

NCT07187635 ·Status: RECRUITING ·Phase: NA

Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer

NCT00872495 ·Status: RECRUITING

Urine-based Molecular Testing vs Cystoscopy for Surveillance of Nonmuscle Invasive Bladder Cancer (NMIBC)

NCT06126796 ·Status: COMPLETED

Urinary Microbiome Differences in Bladder Cancer, Benign Urinary Diseases and Healthy Counterparts in Adult Male Population

NCT06992986 ·Status: RECRUITING

Analysis of Urinary Methylation Patterns Via Liquid Biopsy as an Early Diagnosis Tool

NCT06878027 ·Status: RECRUITING

Establishment and Validation of an Early Diagnostic Model for Bladder Cancer Based on Serum and Urine Metabolomics

NCT04966962 ·Status: UNKNOWN

Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer

NCT07180212 ·Status: RECRUITING ·Phase: NA

Development of a Non-Invasive DNA Methylation-Based Assay System for the Risk Assessment of Urothelial Carcinoma

NCT00867620 ·Status: UNKNOWN

Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder Cancer

NCT06020807 ·Status: COMPLETED

Follow-Up of Bladder Cancer Patients From the New England Study of Environment and Health

NCT00776178 ·Status: COMPLETED

The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma

NCT02700464 ·Status: COMPLETED ·Phase: NA

A Multicenter Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)

NCT06991868 ·Status: RECRUITING

Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance

NCT05796375 ·Status: RECRUITING ·Phase: PHASE2

The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection

NCT06287541 ·Status: RECRUITING ·Phase: NA